Invivyd (IVVD) Retained Earnings (2020 - 2025)
Invivyd (IVVD) posted Retained Earnings of -$41000.0 for Q4 2025, up 100.0% on a QoQ basis from -$943.4 million in Q3 2025, and up 100.0% year-over-year from -$20500.5 in Q4 2024.
Invivyd (IVVD) Retained Earnings (2020 - 2025) Analysis & Trends
Invivyd's Retained Earnings history runs 6 years deep, the most recent figure standing at -$41000.0 for Q4 2025.
- Quarterly Retained Earnings rose 100.0% year-over-year to -$41000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$41000.0 (up 100.0% YoY) and the FY2025 annual result came in at -$41000.0, up 100.0% from the prior year.
- Retained Earnings was -$41000.0 for Q4 2025 at Invivyd, up from -$943.4 million in the prior quarter.
- Across five years, Retained Earnings topped out at $3000.0 in Q3 2021 and bottomed at -$943.4 million in Q3 2025.
- A 5-year average of -$451.2 million and a median of -$533.4 million in 2022 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2023 — Retained Earnings jumped 100.0% — and 2024, when it slumped 44179900.0%.
- Invivyd's Retained Earnings stood at -$8000.0 in 2021, then tumbled by 6667725.0% to -$533.4 million in 2022, then plunged by 37.24% to -$732.1 million in 2023, then decreased by 23.21% to -$902.0 million in 2024, then surged by 100.0% to -$41000.0 in 2025.
- Business Quant data shows IVVD's Retained Earnings at -$41000.0 in Q4 2025, -$943.4 million in Q3 2025, and -$932.9 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | -27.89 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -279.01 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 12.91 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -622,000.00 |
| 10 | Invivyd | 104.07 Mn | -122.62 Mn | 16.07 Mn | -41,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -41,000.00 |
| Sep 30, 2025 | -943.40 Mn |
| Jun 30, 2025 | -932.94 Mn |
| Mar 31, 2025 | -918.30 Mn |
| Dec 31, 2024 | -901.99 Mn |
| Sep 30, 2024 | -883.60 Mn |
| Jun 30, 2024 | -12,000.00 |
| Mar 31, 2024 | -12,000.00 |
| Dec 31, 2023 | -732.07 Mn |
| Sep 30, 2023 | -2,000.00 |
| Jun 30, 2023 | -619.00 Mn |
| Mar 31, 2023 | -568.75 Mn |
| Dec 31, 2022 | -533.43 Mn |
| Sep 30, 2022 | -488.85 Mn |
| Dec 31, 2021 | -8,000.00 |
| Sep 30, 2021 | 3,000.00 |
| Jun 30, 2021 | -148.70 Mn |
| Dec 31, 2020 | -65.32 Mn |